Lilly appeals retatrutide classification ruling in case that could impact compoundersnews2026-02-13T17:31:04+00:00February 13th, 2026|Endpoints News|
AbbVie sues over selection of Botox for IRA negotiationsnews2026-02-12T19:36:28+00:00February 12th, 2026|Endpoints News|
Former AstraZeneca senior staff charged with illegal trade in Chinanews2026-02-11T20:24:40+00:00February 11th, 2026|Endpoints News|
AbbVie, AstraZeneca lose appeal in Louisiana 340B contract pharmacy fightnews2026-02-10T20:06:24+00:00February 10th, 2026|Endpoints News|
Novo Nordisk sues Hims over Wegovy patent infringement, considers seeking ‘hundreds of millions’ in damagesnews2026-02-09T12:04:55+00:00February 9th, 2026|Endpoints News|
HHS drops legal fight over blocked 340B rebate pilotnews2026-02-06T19:19:31+00:00February 6th, 2026|Endpoints News|
Orphan drug tweak in US spending bill will make life easier for the FDAnews2026-02-06T19:10:15+00:00February 6th, 2026|Endpoints News|
FTC settles insulin lawsuit with Express Scriptsnews2026-02-04T20:49:11+00:00February 4th, 2026|Endpoints News|
Rare pediatric PRV program reauthorized until 2029 via government funding lawnews2026-02-04T18:27:40+00:00February 4th, 2026|Endpoints News|
‘Turning around the Titanic’: How the incoming PBM reforms will transform CMSnews2026-02-03T19:34:01+00:00February 3rd, 2026|Endpoints News|
